Page last updated: 2024-10-28

hexamethonium and Cerebral Hemorrhage

hexamethonium has been researched along with Cerebral Hemorrhage in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skarphedinsson, JO1
Delle, M1
Carlsson, S1
Bealer, SL1
Iitake, K1
Share, L1
Brooks, DP1
Crofton, JT1
Ouchi, Y1

Other Studies

2 other studies available for hexamethonium and Cerebral Hemorrhage

ArticleYear
The effects of hexamethonium on cerebral blood flow and cerebral function during relative cerebral ischaemia in rats.
    Acta physiologica Scandinavica, 1996, Volume: 158, Issue:1

    Topics: Animals; Blood Pressure; Brain Ischemia; Brain Stem; Cerebral Hemorrhage; Cerebrovascular Circulatio

1996
Role of brain acetylcholine in vasopressin release during osmotic stimulation and hemorrhage.
    Experimental brain research, 1989, Volume: 75, Issue:1

    Topics: Acetylcholine; Animals; Atropine; Cerebral Hemorrhage; Cholinergic Fibers; Hexamethonium; Hexamethon

1989